Table 2:
Individual biomarker results for Lysine metabolism group pathway
| Metabolite | P-value for association with risk of breast cancer | P-value for association with BMI |
|---|---|---|
| 2-Aminoadipate | 0.43 | 5.3∙10−4 |
| 3-Methylglutarylcarnitine-1* | 9.5∙10−5 | 2.0∙10−8 |
| 3-Methylglutarylcarnitine-2 | 0.02 | 0.31 |
| Glutarate pentanedioate | 0.82 | 0.96 |
| Lysine | 0.35 | 0.25 |
| N6-Trimethyl-L-lysine | 0.13 | 0.02 |
| N2-Acetyl-L-lysine | 0.28 | 0.09 |
| N6-Acetyl-L-lysine | 0.17 | 0.55 |
| Pipecolate | 0.64 | 0.26 |
| 3-Methylglutaconate | 0.62 | 0.82 |
Metabolite discovered by TS and MIN to mediate effect of BMI